Pain relief for hormone therapy symptoms in early breast cancer
Treatments studied
Part of Bones, joints & muscles, Cancer, Pain, Skin clinical trials.
This trial tests two supportive treatments (duloxetine and furosemide) to help relieve muscle, joint, and bone pain caused by hormone therapy for early breast cancer. The goal is to improve your quality of life while continuing your cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female (any age) or male, 18 years or older.
- You have early-stage breast cancer (stage I, II, or III) that is ER-positive and HER2-negative.
- You have been on hormone therapy (tamoxifen or an aromatase inhibitor) for at least 3 months but no more than 3 years.
- You have muscle, joint, or bone pain from hormone therapy that is at least moderate and limits daily activities (like housework or shopping).
- If you had chemotherapy before, it must have ended at least 3 months ago.
- You must be able to complete questionnaires about your quality of life.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral solution of cannabidiol (CBD), a non-psychoactive cannabis compound, to see if it can ease joint pain caused by aromatase inhibitor therapy for early breast cancer. If it works, it could offer a new way to manage this common side effect.
This study tests a program of care to help with joint and muscle pain caused by aromatase inhibitor therapy, a common treatment for breast cancer. It aims to reduce pain and improve quality of life for people taking these medications.
This trial studies whether Chinese herbs, used alongside letrozole, can reduce ongoing joint and muscle pain or stiffness in postmenopausal women with hormone-receptor positive breast cancer. It’s mainly for people whose pain started or worsened after beginning letrozole and who have completed cancer treatments.
This trial tests if a supervised exercise program can improve quality of life for people with early-stage breast cancer who are currently taking hormone therapy (aromatase inhibitors with or without CDK4/6 inhibitors). It aims to see if exercise helps reduce side effects like fatigue and pain.
This trial tests whether a yoga program can help reduce joint and muscle pain caused by hormone therapy (like tamoxifen or aromatase inhibitors) in people with breast cancer. You must have finished your main treatments at least 12 weeks ago and have had pain for more than 3 months.
This trial is testing a lower dose of treatment for women with small, early-stage breast cancer that is hormone-positive and has not spread to lymph nodes. The goal is to find out if it can be as effective as the standard treatment with fewer side effects.
Hear when a new ER+ Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.